Physician profile
Sonya Mack
NPI 1558059402
$3,818.49
in general payments reported to CMS, 2019-2025
22 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,173 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,818.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $561.04 | 2024-2025 | Caplyta |
| Abbvie INC. | $549.11 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $435.27 | 2024-2025 | Trintellix |
| Corium, LLC | $396.71 | 2024-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $338.98 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $260.11 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $259.42 | 2024-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $200.34 | 2024-2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $191.34 | 2024-2025 | Cobenfy |
| Neos Therapeutics, Lp | $150.36 | 2024-2025 | Adzenys Xr-Odt, Metadate Cd, Cotempla Xr-Odt |
| Bausch Health US, LLC | $95.38 | 2024-2025 | Aplenzin, Wellbutrin |
| Supernus Pharmaceuticals, INC. | $89.52 | 2024-2025 | Qelbree |
| Almatica Pharma LLC | $64.83 | 2024 | Loreev Xr |
| Noven Therapeutics, LLC | $41.25 | 2024 | Xelstrym, Secuado |
| Vertical Pharmaceuticals, LLC | $39.36 | 2024 | Relexxii |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.16 | 2024 | Invega Sustenna, Spravato |
| Abc Home Medical Supply, INC. | $19.90 | 2024 | |
| Ironshore Pharmaceuticals INC. | $19.60 | 2024 | |
| Hologic Sales and Service, LLC | $19.44 | 2024 | Coolseal Generator |
| Tris Pharma INC | $16.92 | 2024 | Dyanavel Xr |
| Biogen, INC. | $16.76 | 2025 | Zurzuvae |
| Collegium Pharmaceutical, INC. | $14.69 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Mack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.